For the twelve months ended Jun 30, 2026, Tao Synergies Inc. reported $772.5K of revenue and -$16.65M of net income.
TAOX revenue was $88.6K in fiscal Q2 2026 (ended Jun 30, 2026), up about 22-fold from a year earlier and down 77.2% from the prior quarter. For the full fiscal 2025 it was $299.1K, compared with $0 in fiscal 2024.
TAOX net income was -$9.30M in fiscal Q2 2026 (ended Jun 30, 2026), compared with -$17.52M a year earlier. For the full fiscal 2025 it was -$28.74M, compared with -$12.77M in fiscal 2024.
TAOX diluted EPS was -$1.83 in fiscal Q2 2026 (ended Jun 30, 2026). For the full fiscal 2025 it was -$8.81.
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $299.1K | $0 | - | - | - | - | - |
| Cost of revenue | $38.3K | $0 | - | - | - | - | - |
| Gross profit | $260.8K | $0 | - | - | - | - | - |
| Research and development | $322.2K | $1.60M | $1.97M | $6.32M | $4.34M | $3.07M | $5.67M |
| Selling, general and admin | $9.02M | $5.21M | $6.34M | $9.81M | $8.28M | $8.09M | $9.57M |
| Operating income | -$9.05M | -$6.81M | - | - | - | - | - |
| Pre-tax income | -$28.74M | -$12.77M | -$6.04M | -$5.57M | -$12.61M | -$12.70M | -$15.13M |
| Income tax | $0 | $0 | $0 | - | - | - | - |
| Net income | -$28.74M | -$12.77M | -$6.04M | -$5.57M | -$12.61M | -$12.70M | -$15.13M |
| EPS, basic | -$8.81 | -$10.99 | $29.56 | -$0.81 | $2.51 | $12.03 | $3.01 |
| EPS, diluted | -$8.81 | -$10.99 | $29.56 | -$0.81 | $2.51 | $12.03 | $3.01 |
| Diluted shares | 3.3M | 1.2M | 466,100 | 7.0M | 5.0M | 1.3M | 5.0M |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | $5.50M | $17.66M | $28.66M | $37.48M | $34.21M | $5.80M | $17.38M |
| Current assets | $25.38M | $17.72M | $30.53M | $38.59M | $35.50M | $6.73M | $17.88M |
| Total assets | $25.84M | $17.73M | $31.11M | $38.61M | $35.52M | $6.75M | $17.90M |
| Current liabilities | $1.81M | $1.01M | $4.28M | $1.31M | $1.99M | $1.61M | $479.1K |
| Total liabilities | $3.94M | $10.96M | $5.53M | $3.19M | $1.99M | - | - |
| Shareholders' equity | $21.05M | $5.86M | $24.35M | $32.69M | $33.53M | $5.14M | $17.42M |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -$6.40M | -$4.88M | -$5.17M | -$11.21M | -$8.71M | -$8.10M | -$11.89M |
| Capital expenditures | - | - | $2.7K | $7.4K | $3.2K | $5.4K | $5.2K |
| Free cash flow | - | - | -$5.18M | -$11.22M | -$8.71M | -$8.11M | -$11.89M |
| Investing cash flow | -$28.89M | -$1.00M | -$2.00M | -$7.4K | -$3.2K | -$5.4K | -$5.2K |
| Financing cash flow | $23.13M | -$5.12M | -$1.64M | $14.48M | $37.13M | -$3.48M | $419.8K |
| Depreciation and amortization | $3.6K | $5.6K | $6.3K | $5.7K | $5.0K | $4.9K | $4.4K |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|---|
| Gross margin | 87.2% | - | - | - | - | - | - |
| Operating margin | -3025.2% | - | - | - | - | - | - |
| Net margin | -9609.2% | - | - | - | - | - | - |
| Return on equity | -136.5% | -217.8% | -24.8% | -17.0% | -37.6% | -247.2% | -86.9% |
| Return on assets | -111.2% | -72.0% | -19.4% | -14.4% | -35.5% | -188.2% | -84.6% |
| Current ratio | 13.99 | 17.47 | 7.14 | 29.39 | 17.80 | 4.17 | 37.32 |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $88.6K | $388.8K | $91.7K | $203.4K | $4.0K | $0 | - | - | - | - | - | - |
| Cost of revenue | $22.1K | $17.4K | - | - | - | - | - | - | - | - | - | - |
| Gross profit | $66.6K | $371.4K | - | - | - | - | - | - | - | - | - | - |
| Research and development | $31.9K | $28.6K | $58.5K | $54.4K | $148.6K | $60.8K | $424.5K | $222.9K | $342.1K | $609.2K | $577.9K | $212.1K |
| Selling, general and admin | $1.63M | $1.68M | $3.88M | $1.95M | $2.19M | $1.01M | $1.75M | $1.14M | $1.24M | $1.08M | $1.55M | $1.22M |
| Operating income | -$1.57M | -$1.32M | -$3.14M | -$1.80M | -$3.04M | -$1.07M | -$1.56M | -$1.98M | -$1.58M | -$1.69M | - | - |
| Pre-tax income | -$9.30M | $4.25M | -$7.68M | -$3.92M | -$17.52M | $385.2K | -$5.55M | -$5.74M | -$1.27M | -$206.7K | -$996.0K | $763.2K |
| Income tax | $0 | $0 | - | - | $0 | $0 | - | - | - | - | - | - |
| Net income | -$9.30M | $4.25M | -$7.68M | -$3.92M | -$17.52M | $385.2K | -$5.55M | -$5.74M | -$1.27M | -$206.7K | -$996.0K | $763.2K |
| EPS, basic | -$1.83 | $0.45 | - | -$1.56 | -$11.26 | $0.12 | - | -$5.01 | -$1.18 | -$0.41 | - | $0.84 |
| EPS, diluted | -$1.83 | $0.43 | - | -$1.56 | -$11.26 | $0.04 | - | -$5.01 | -$1.18 | -$0.41 | - | $0.84 |
| Diluted shares | 7.5M | 7.7M | - | 2.5M | 1.6M | 1.4M | - | 1.2M | 1.2M | 1.0M | - | 428,200 |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $2.37M | $3.65M | $5.50M | $1.45M | $14.37M | $14.83M | $17.66M | $19.63M | $24.98M | $26.33M | $28.66M | $31.73M |
| Current assets | $20.62M | $30.24M | $25.38M | $18.35M | $19.78M | $15.32M | $17.72M | $22.28M | $27.83M | $28.83M | $30.53M | $32.34M |
| Total assets | $21.10M | $31.05M | $25.84M | $18.36M | $19.79M | $15.33M | $17.73M | $22.83M | $28.39M | $29.40M | $31.11M | $32.36M |
| Current liabilities | $1.03M | $1.10M | $1.81M | $1.04M | $964.3K | $210.7K | $1.01M | $340.9K | $9.35M | $6.30M | $4.28M | $1.82M |
| Total liabilities | $3.81M | $4.88M | $3.94M | $1.69M | $1.83M | $8.88M | $10.96M | $9.71M | $9.59M | $6.52M | $5.53M | $3.93M |
| Shareholders' equity | $12.75M | $23.26M | $21.05M | $16.07M | $17.25M | $5.17M | $5.86M | $12.80M | $18.80M | $22.05M | $24.35M | $26.74M |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$875.0K | -$1.68M | -$2.45M | -$1.19M | -$749.1K | -$2.00M | -$1.17M | -$1.03M | -$853.5K | -$1.83M | -$1.07M | -$1.17M |
| Capital expenditures | - | - | - | - | - | - | - | - | - | - | $0 | $0 |
| Free cash flow | - | - | - | - | - | - | - | - | - | - | -$1.07M | -$1.17M |
| Investing cash flow | - | - | -$11.32M | -$13.07M | - | - | $0 | $0 | -$500.0K | -$500.0K | -$2.00M | $0 |
| Financing cash flow | -$402.4K | -$169.0K | $17.83M | $1.34M | $4.79M | -$822.4K | -$801.7K | - | - | - | -$51 | $49 |
| Depreciation and amortization | $735 | $816 | $802 | $803 | $979 | $1.0K | $1.2K | $1.7K | $1.3K | $1.4K | $1.2K | $1.7K |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | 2136.9% | - | - | - | - | - | - | - | - | - | - | - |
| Net income growth, YoY | - | 1004.6% | - | - | - | - | - | - | - | - | - | - |
| Gross margin | 75.1% | 95.5% | - | - | - | - | - | - | - | - | - | - |
| Operating margin | -1770.6% | -339.0% | -3426.1% | -884.8% | -76623.8% | - | - | - | - | - | - | - |
| Net margin | -10492.4% | 1094.3% | -8376.2% | -1929.1% | -442101.9% | - | - | - | - | - | - | - |
| Current ratio | 19.99 | 27.40 | 13.99 | 17.61 | 20.51 | 72.71 | 17.47 | 65.36 | 2.98 | 4.58 | 7.14 | 17.79 |
Source: XBRL data Tao Synergies Inc. files with the SEC, latest filing dated Aug 13, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.
Per-share figures are as filed. The filings show no stock split in these periods.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| TAOX | $772.5K | - | -$16.65M | -2155.5% | $22.1M |
| AXP | $77.59B | +10.2% | $12.26B | 15.8% | $217.47B |
| SPGI | $17.21B | +18.2% | $4.99B | 29.0% | $136.57B |
| MCO | $8.18B | +9.0% | $2.88B | 35.3% | $88.11B |
| NU | $15.77B | +37.0% | $2.87B | 18.2% | $60.02B |
| RKT | $11.46B | +90.4% | $1.30B | 11.4% | $43.11B |
| COIN | $5.63B | -26.6% | -$701.62M | -12.5% | $36.03B |
| AFRM | $4.59B | +32.7% | $2.01B | 43.9% | $23.06B |
| SYF | $19.31B | +2.6% | $3.33B | 17.3% | $22.80B |